CanGene-CanVar is a five-year CRUK-funded research program developing data resources, clinical and educational tools to leverage cancer susceptibility ...

The 5-year CanGene-CanVar programme (April 2019 - March 2024) aims to create an interface between NHS and research settings that will underpin future ...

A five year project to centralise data and create an interface between the NHS and research groups which will underpin future expansions in genetic testing.

3 ијн 2024 · CanGeneCanVar (CGCV) is a 5-year £4.3 million Cancer Research UK (CRUK) catalyst-award funded research programme aiming to 'create an ...

Our work package aims to develop web-based decision aids to support decisions following a genetic test about risk management.

4 ијн 2024 · We achieved consensus for UK best practice in use of CanRisk in making recommendations for breast cancer surveillance, eligibility for genetic testing.

4 ијн 2024 · We achieved consensus for UK best practice in use of CanRisk in making recommendations for breast cancer surveillance, eligibility for genetic testing.

The National Cancer Genetics MDT is a collaboration between UK CGG and the CanGene-CanVar Programme which aims to create a regular national forum to discuss ...

CanGene-CanVar: data sources, clinical and educational tools to leverage cancer susceptibility genetics for prevention and early detection of cancer.

4 ијн 2024 · CanRisk provides an individualised risk assessment by incorporating personal and family history of cancer, as well as predictive and diagnostic ...